Inventor
MIYAMOTO YASUFUMI
JP14 patents
⚠️ This page may combine multiple inventors who share the name “MIYAMOTO YASUFUMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
5 patentsUS11186565B2Nov 30, 2021
Aromatic compound
TAKEDA PHARMACEUTICALS CO3 citations71
US9776962B2Oct 3, 2017
Aromatic compounds with GPR40 agonistic activity
TAKEDA PHARMACEUTICALS CO2 citations70
US10519110B2Dec 31, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations59
US10968231B2Apr 6, 2021
Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders
TAKEDA PHARMACEUTICALS CO0 citations50
US10189785B2Jan 29, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations49
CARDURION PHARMACEUTICALS LLC
3 patentsUS10543212B2Jan 28, 2020
Substituted amines for treating cardiac diseases
CARDURION PHARMACEUTICALS LLC10 citations80
US11197858B2Dec 14, 2021
Substituted amines for treating cardiac diseases
CARDURION PHARMACEUTICALS LLC0 citations59
US11130752B2Sep 28, 2021
Aminopyrimidine compound
CARDURION PHARMACEUTICALS LLC0 citations49
YASUMA TSUNEO
2 patentsTAKEDA PHARMACEUTICAL
2 patentsCARDURION PHARMACEUTICALS INC
2 patentsUS12528816B2Jan 20, 2026
Substituted imidazo [1,2-b] pyridazines and [1, 2, 4] triazolo [ 4,3-b] pyridazines as camkii inhibitors
CARDURION PHARMACEUTICALS INC0 citations59
US11795172B2Oct 24, 2023
Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitors
CARDURION PHARMACEUTICALS INC0 citations59